Save time and jump to the most important pieces.
FAIRPORT, N.Y., Oct. 21, 2022 /PRNewswire/ -- Manning & Napier, Inc. (NYSE:MN), ("Manning & Napier" or "the Company") today announced the completion of its process to go private and be acquired by Callodine Group LLC ("Callodine"), a Boston-based asset management firm. The transaction was announced on April 1, 2022 and received shareholder approval on August 3, 2022. Under the terms of the go-private transaction, Manning & Napier stockholders will receive $12.85 per share in cash. With the completion of the acquisition, Manning & Napier's common stock has ceased trading and will no longer be listed on the New York Stock Exchange. "We are excited to complete the acquisition of Manning & Napie
FAIRPORT, N.Y., Oct. 12, 2022 /PRNewswire/ -- Manning & Napier, Inc. (NYSE:MN), ("Manning & Napier" or "the Company") today reported preliminary assets under management ("AUM") as of September 30, 2022 of $17.4 billion, which included approximately $12.4 billion in separately managed accounts and approximately $5.0 billion in mutual funds and collective investment trusts. Transaction Update As previously announced, Manning & Napier expects to complete its transaction with Callodine Group in October 2022. About Manning & Napier, Inc. Manning & Napier (NYSE:MN) provides a broad range of investment solutions through separately managed accounts, mutual funds, and collective investment trust fund
FAIRPORT, N.Y., Sept. 28, 2022 /PRNewswire/ -- Manning & Napier, Inc. (NYSE:MN), ("Manning & Napier" or "the Company") today announced the extension of the outside date under the merger agreement with Callodine Group LLC ("Callodine") to December 1, 2022. "We continue to work diligently to conclude the regulatory review processes necessary to close our transaction," said Marc Mayer, Chairman and CEO of Manning & Napier. "In order to continue to productively engage with the regulators, we have revised our outlook and now expect the transaction to close in October 2022. We appreciate the continued support of our employees, clients and shareholders and look forward to the Company's next chapter
DECATUR, AL / ACCESSWIRE / February 24, 2021 / Lakeland Industries, Inc. (NASDAQ:LAKE) (the "Company" or "Lakeland"), a leading global manufacturer of protective clothing for industry, healthcare and to first responders on the federal, state and local levels, today announced the appointment of investment industry veteran Nikki Hamblin to its Board of Directors (the "Board"). The appointment increases the number of directors to seven, five of whom are independent. Christopher J. Ryan, Executive Chairman of Lakeland Industries, commented, "We are pleased to have Nikki join our Board to enhance our sound governance and solid succession planning. Her appointment and the increased size of our Bo
4 - Manning & Napier, Inc. (0001524223) (Issuer)
4 - Manning & Napier, Inc. (0001524223) (Issuer)
4 - Manning & Napier, Inc. (0001524223) (Issuer)
SC 13G/A - Manning & Napier, Inc. (0001524223) (Subject)
SC 13D/A - Manning & Napier, Inc. (0001524223) (Subject)
SC 13G/A - Manning & Napier, Inc. (0001524223) (Subject)
Manning & Napier (NYSE:MN) reported quarterly earnings of $0.11 per share. This is a 64.52 percent decrease over earnings of $0.31 per share from the same period last year. The company reported quarterly sales of $33.80 million which beat the analyst consensus estimate of $30.00 million by 12.67 percent. This is a 6.31 percent decrease over sales of $36.08 million the same period last year.
Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings for its second quarter. • Kandi Technologies Gr (NASDAQ:KNDI) is projected to report earnings for its second quarter. • Tredegar (NYSE:TG) is estimated to report earnings for its second quarter. • PowerFleet (NASDAQ:PWFL) is likely to report quarterly loss at $0.12 per share on revenue of $34.36 million. • PDS Biotechnology (NASDAQ:PDSB) is projected to report earnings for its second quarter. • LENSAR (NASDAQ:LNSR) is expected to report quarterly loss at $0.72 per share on revenue of $9.30 million. • Precision BioSciences (NASDAQ:DTIL) is likely to report quarterly loss at $0.41 per share
EFFECT - Manning & Napier, Inc. (0001524223) (Filer)
15-12G - Manning & Napier, Inc. (0001524223) (Filer)
S-8 POS - Manning & Napier, Inc. (0001524223) (Filer)
FAIRPORT, N.Y., Aug. 9, 2022 /PRNewswire/ -- Manning & Napier, Inc. (NYSE:MN), ("Manning & Napier" or the "Company") today reported 2022 second quarter results for the period ended June 30, 2022. "Broad and significant declines across capital markets globally continued in the second quarter, pressuring revenues and causing mark-to-market declines in securities held on the balance sheet," commented Marc Mayer, Chairman of the Board and Chief Executive Officer of Manning & Napier. "We are managing our expenses thoughtfully and we are entirely focused on delivering excellent results and superior service for our clients." Mr. Mayer added, "We are progressing toward the completion of our previous
FAIRPORT, N.Y., July 22, 2022 /PRNewswire/ -- Manning & Napier, Inc. (NYSE:MN), ("Manning & Napier" or "the Company") today announced that its Board of Directors has declared a quarterly dividend of $0.05 per share of Class A common stock. The dividend will be paid on or about August 19, 2022 to shareholders of record as of the close of business on August 5, 2022. About Manning & Napier, Inc.Manning & Napier (NYSE:MN) provides a broad range of investment solutions through separately managed accounts, mutual funds, and collective investment trust funds, as well as a variety of consultative services that complement our investment process. Founded in 1970, we offer equity, fixed income and alt
FAIRPORT, N.Y., July 13, 2022 /PRNewswire/ -- Manning & Napier, Inc. (NYSE:MN), ("Manning & Napier" or "the Company") today announced that it expects to release its second quarter 2022 financial results the week of August 8th, 2022, in conjunction with its related 10-Q filing. In light of the previously announced definitive agreement to be acquired by Callodine Group, the Company will not host a conference call to discuss second quarter 2022 financial results. Assets Under ManagementThe Company also announced that preliminary June 30, 2022 assets under management ("AUM") were $18.5 billion, which included approximately $13.3 billion in separately managed accounts and approximately $5.2 billi